These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 18385183)

  • 1. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
    Glasmacher SA; Leigh PN; Saha RA
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):402-411. PubMed ID: 28250027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.
    dell'Aquila C; Zoccolella S; Cardinali V; de Mari M; Iliceto G; Tartaglione B; Lamberti P; Logroscino G
    Parkinsonism Relat Disord; 2013 Nov; 19(11):980-5. PubMed ID: 23968651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.
    Jecmenica-Lukic M; Petrovic IN; Pekmezovic T; Kostic VS
    J Neurol; 2014 Aug; 261(8):1575-83. PubMed ID: 24888315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
    Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL
    Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.
    Lee SW; Koh SB
    J Mov Disord; 2012 Oct; 5(2):42-7. PubMed ID: 24868413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ; Jeong SJ; Kim JM
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in progressive supranuclear palsy.
    Mahale RR; Krishnan S; Divya KP; Jisha VT; Kishore A
    Acta Neurol Belg; 2022 Apr; 122(2):357-362. PubMed ID: 33595832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of falls in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a retrospective study.
    Altmann CF; Koschel J; Jost WH
    Neurol Neurochir Pol; 2023; 57(3):297-304. PubMed ID: 37161947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.
    Bensimon G; Ludolph A; Agid Y; Vidailhet M; Payan C; Leigh PN;
    Brain; 2009 Jan; 132(Pt 1):156-71. PubMed ID: 19029129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PSP phenotypes with survival: A brain-bank study.
    Guasp M; Molina-Porcel L; Painous C; Caballol N; Camara A; Perez-Soriano A; Sánchez-Gómez A; Garrido A; Muñoz E; Marti MJ; Valldeoriola F; Grau O; Gelpí E; Respondek G; Höglinger GH; Compta Y
    Parkinsonism Relat Disord; 2021 Mar; 84():77-81. PubMed ID: 33581485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
    Testa D; Monza D; Ferrarini M; Soliveri P; Girotti F; Filippini G
    Neurol Sci; 2001 Jun; 22(3):247-51. PubMed ID: 11731878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy.
    Oliveira MCB; Ling H; Lees AJ; Holton JL; De Pablo-Fernandez E; Warner TT
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):555-561. PubMed ID: 30598430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P; Zhang J; Han J; Ji Y
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.